Q1 the outcome is not impressive at all but month of April showing impressive turnaround. If they can build up the MSV to $ 60 m for Q2 then there will be no looking back...till then we have to wait.
- Forums
- ASX - By Stock
- SPT
- Ann: Quarterly Report (Appendix 4C)
Ann: Quarterly Report (Appendix 4C), page-24
-
- There are more pages in this discussion • 129 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online